Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Mar;22(3):327-34.
doi: 10.1007/s00192-010-1287-x. Epub 2010 Oct 13.

Correlates and predictors of patient satisfaction with drug therapy and combined drug therapy and behavioral training for urgency urinary incontinence in women

Patricia S Goode  1 , Kathryn L Burgio, Stephen R Kraus, Kimberly Kenton, Heather J Litman, Holly E Richter; Urinary Incontinence Treatment Network
Collaborators, Affiliations
Randomized Controlled Trial

Correlates and predictors of patient satisfaction with drug therapy and combined drug therapy and behavioral training for urgency urinary incontinence in women

Patricia S Goode et al. Int Urogynecol J. 2011 Mar.

Abstract

Introduction and hypothesis: The goal was to identify correlates of patient satisfaction with drug and behavioral treatments for urge-predominant incontinence, which may help tailor treatments to improve satisfaction.

Methods: Planned secondary analysis of a multi-center, clinical trial randomizing 307 women to 10 weeks of tolterodine alone or combined with behavioral training. Satisfaction was measured using the Patient Satisfaction Question (PSQ). Potential correlates included baseline demographics, incontinence characteristics and prior treatments, history and physical parameters, expectations of treatment success, and outcome variables including the Global Perception of Improvement (GPI) and Urogenital Distress Inventory (UDI).

Results: After multivariable analysis, every 10-point increase in UDI change score increased odds of satisfaction by 11% (OR 1.11; 1.04-1.19). Odds of satisfaction increased among women reporting "much better" on the GPI (OR 13.8; 4.94-38.60).

Conclusions: Treatment satisfaction for women with urge-predominant incontinence was associated with patient-related outcomes reflecting impression of improvement and bother from incontinence-related symptoms.

Trial registration: ClinicalTrials.gov NCT00090584.

PubMed Disclaimer

References

    1. Richter HE, Burgio KL, Goode PS, Borello-France D, Bradley CS, Brubaker L, Handa VL, Fine PM, Visco AG, Zyczynski HM, Wei JT, Weber AM. Non-Surgical Management of Stress Urinary Incontinence: Ambulatory Treatments for Leakage Associated with Stress (ATLAS) Trial. Clinical Trials. 2007;4:92–101. - PubMed
    1. Brubaker L, Richter HE, Visco AG, et al. Refractory Idiopathic Urge incontinence and Botulinum A Injection. J Urology. 2008;180:217–222. - PMC - PubMed
    1. Burgio KL, Goode PS, Richter HE, Locher JL, Roth DL. Global Ratings of Patient Satisfaction and Perceptions of Improvement with Treatment for Urinary Incontinence: Validation of Three Global Patient Ratings. Neurourology and Urodynamics. 2006;25:411–417. - PubMed
    1. Kraus S, Burgio K, Goode P, Richter H for the Urinary Incontinence Treatment Network. Design of the behavioral enhances drug reduction of incontinence (BE-DRI) study. Contemporary Clinical Trials. 2007;28(1):48–58. - PubMed
    1. Burgio KL, Kraus SR, Menefee S, et al. Behavioral therapy to enable women with urge incontinence to discontinue drug treatment. Ann Int Med. 2008;149:161–169. - PMC - PubMed

Publication types

Associated data

LinkOut - more resources